WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a definitive ...

(Reuters) -Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration business for about $4.1 billion, sending the latter's shares up ...

Thermo Scientific™ KingFisher™ PlasmidPro prepares high purity plasmid DNA in approximately 75 minutes, half the traditional process time and without the need for centrifugation WALTHAM, ...

The trend of corporate pruning in med tech continues with Solventum Corp.’s decision to sell its purification and filtration business to Thermo Fisher Scientific Inc. for $4.1 billion. The ...

On Tuesday, Thermo Fisher Scientific Inc. (NYSE:TMO) agreed to acquire Solventum’s (NYSE:SOLV) Purification & Filtration business for approximately $4.1 billion in cash. Solventum’s Purification & ...

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...

Thermo Fisher Scientific is buying Solventum‘s purification and filtration business for $4.1 billion. Magnet Bio and Eli Lilly entered into a collaboration that could reach $1.25 billion in value.

Highly Complementary to Thermo Fisher’s Bioproduction Business and Strengthens Offering in the High Growth Bioprocessing Market WALTHAM, Mass.--(BUSINESS WIRE)-- Thermo Fisher Scientific Inc. (TMO) ...

WALTHAM, Mass.--(BUSINESS WIRE)-- Thermo Fisher Scientific Inc. (TMO) (“Thermo Fisher”), the world leader in serving science, today announced the completion of its acquisition of the Purification & ...

Thermo Fisher Scientific agreed to acquire Solventum’s purification and filtration (PF) business for approximately $4.1 billion in cash. The PF business provides purification and filtration ...